Merck Balks At $4.6M Verdict In Mass. Medicaid Case

Law360, New York (September 30, 2010, 7:28 PM EDT) -- Merck & Co. Inc. vowed Thursday to fight a $4.6 million jury verdict against the drugmaker in a suit alleging that a defunct subsidiary of Schering-Plough Corp. — which is now owned by Merck — reported inflated prices for albuterol to the Massachusetts Medicaid program.

A jury in the U.S. District Court for the District of Massachusetts on Thursday awarded the state damages in the amount of $4.56 million following a three-week trial.

The long-running case was originally filed by Massachusetts in 2003. The drugs at...
To view the full article, register now.



Case Information

Case Title

The Commonwealth of Massachusetts v. Mylan Laboratories, Inc. et al

Case Number




Nature of Suit

Fraud or Truth-In-Lending


Patti B. Saris

Date Filed

October 1, 2003

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.